Nicole White

Nicole White

Corporate Officer/Principal bei ASSEMBLY BIOSCIENCES, INC.

Vermögen: 171 716 $ am 30.04.2024

44 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Nicole White

EinheitArt der EinheitIndustrie
Public Company Biotechnology 68
Public Company Pharmaceuticals: Major 23
Public Company Pharmaceuticals: Major 12
3
Subsidiary Pharmaceuticals: Other 3

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Nicole White

UnternehmenSektorVerknüpfte PersonenHauptposition
Stanford University College/University

Paul A. Berg

Jason Okazaki

Christopher Griffith

Robert Janssen

Jung Choi

Wayne Godfrey

Marni Kottle

Anuj Gaggar

Corporate Officer/Principal

Undergraduate Degree

Graduate Degree

Undergraduate Degree

Masters Business Admin

Graduate Degree

Undergraduate Degree

Undergraduate Degree

College/University

John McHutchison

Robert Janssen

Qing Qing Yi

William Guyer

Robert Cook

Corporate Officer/Principal

Doctorate Degree

Masters Business Admin

Doctorate Degree

Masters Business Admin

AMGEN INC. Pharmaceuticals: Major

Susan Mahony

Kevin B. Young

Roy Baynes

Kenneth Lock

Christophe Quéva

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Christopher Griffith

Jakob Dupont

Russell Cox

Philippe C. Bishop

Ashraf Amanullah

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Per Wold-Olsen

Roy Baynes

Roger Dansey

Lisa Johnson-Pratt

Yuan Xu

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of California, Los Angeles College/University

Kenneth F. Boehm

Muzammil Mansuri

Susan T. Hubbard

Philip T. Sager

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Corporate Officer/Principal

INTERMUNE INC Biotechnology

William Ringo

Jung Choi

Carla Fiankan

Elizabeth Ann Fagan

Chief Executive Officer

Corporate Officer/Principal

General Counsel

Director/Board Member

The University of Chicago Booth School of Business College/University

Robert Nelsen

Helen Kim

Dennis D. Self

Thomas Russo

Masters Business Admin

Graduate Degree

Masters Business Admin

Masters Business Admin

KRONOS BIO, INC. Pharmaceuticals: Major

Otello Stampacchia

Phillip Gutry

Roger Dansey

Marni Kottle

Director/Board Member

Corporate Officer/Principal

Director/Board Member

Investor Relations Contact

ELI LILLY AND COMPANY Pharmaceuticals: Major

Richard DiMarchi

Susan Mahony

William Ringo

Josh Bilenker

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

EXELIXIS, INC. Pharmaceuticals: Major

Susan T. Hubbard

Scott Ogg

Jeffrey Hessekiel

Christopher Senner

Investor Relations Contact

Chief Tech/Sci/R&D Officer

General Counsel

Director of Finance/CFO

College/University

Uri Lopatin

Michael Sofia

Kenneth Lock

Undergraduate Degree

Undergraduate Degree

Masters Business Admin

College/University

Louis Lange

Alan Montgomery

Anuj Gaggar

Corporate Officer/Principal

Doctorate Degree

Doctorate Degree

Massachusetts Institute of Technology College/University

Laura Carter

Philip T. Sager

Chan Beals

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

IONIS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Richard DiMarchi

Anthony Altig

Lisa Johnson-Pratt

Director/Board Member

Comptroller/Controller/Auditor

Corporate Officer/Principal

DERMIRA, INC. Pharmaceuticals: Major

William Ringo

Christopher Griffith

Stephen Cheng

Director/Board Member

Founder

Corporate Officer/Principal

Miscellaneous Commercial Services

Anthony Altig

Elvia Cowan

Robert Cook

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

KITE PHARMA INC Biotechnology

Helen Kim

Jason Okazaki

Wayne Godfrey

Private Equity Investor

Director/Board Member

Chief Tech/Sci/R&D Officer

CORCEPT THERAPEUTICS INCORPORATED Pharmaceuticals: Major

Renée Galá

Monica Tellado

William Guyer

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Helen Kim

William Ringo

Michael Samar

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Golden Gate University College/University

Kenneth F. Boehm

Maria Fardis

Craig S. Gibbs

Doctorate Degree

Masters Business Admin

Masters Business Admin

SANOFI Biotechnology

Muzammil Mansuri

John Sundy

Corporate Officer/Principal

Director/Board Member

BELLEROPHON THERAPEUTICS, INC. Pharmaceuticals: Major

Robert Nelsen

Hunter Gillies

Director/Board Member

Chief Tech/Sci/R&D Officer

Princeton University College/University

Josh Bilenker

Rajesh Krishnan

Undergraduate Degree

Undergraduate Degree

ACELYRIN, INC. Pharmaceuticals: Major

Shao Lee Lin

Kenneth Lock

Founder

Corporate Officer/Principal

AURA BIOSCIENCES, INC. Biotechnology

Sapna R. Srivastava

Langdon L. Miller

Director/Board Member

Director/Board Member

PROQR THERAPEUTICS N.V. Pharmaceuticals: Major

Noreen Henig

Smital Shah

Corporate Officer/Principal

Director of Finance/CFO

Yale University College/University

Alan J. Lewis

Noreen Henig

Corporate Officer/Principal

Undergraduate Degree

ARRAY TECHNOLOGIES, INC. Pharmaceuticals: Major

Robert Nelsen

Laura Carter

Director/Board Member

Corporate Officer/Principal

INNOVIVA, INC. Pharmaceuticals: Major

Sapna R. Srivastava

Renée Galá

Director/Board Member

Corporate Officer/Principal

FATE THERAPEUTICS, INC. Biotechnology

Robert Nelsen

Yuan Xu

Director/Board Member

Director/Board Member

NEKTAR THERAPEUTICS Pharmaceuticals: Major

Scott Ogg

Diana Brainard

Corporate Officer/Principal

Director/Board Member

QUINCE THERAPEUTICS, INC. Biotechnology

Kevin B. Young

Christopher Senner

Director/Board Member

Director/Board Member

University of California San Diego College/University

Linda Higgins

Kenneth Lock

Doctorate Degree

Undergraduate Degree

Medical Specialties

Philip T. Sager

Uri Lopatin

Director/Board Member

Private Equity Investor

Scripps Clinic & Research Foundation

David Gollaher

John McHutchison

Public Communications Contact

Corporate Officer/Principal

University of California, Santa Barbara College/University

David Gollaher

Wayne Godfrey

Undergraduate Degree

Undergraduate Degree

CYMABAY THERAPEUTICS, INC. Biotechnology

Kenneth F. Boehm

Louis Lange

Human Resources Officer

Chairman

BIOMARIN PHARMACEUTICAL INC. Biotechnology

Alan J. Lewis

Marni Kottle

Director/Board Member

Public Communications Contact

Notre Dame de Namur University College/University

Carla Fiankan

Stephen Cheng

Undergraduate Degree

Masters Business Admin

Miscellaneous Commercial Services

Muzammil Mansuri

Mani Subramanian

Director/Board Member

Founder

University College London College/University

Muzammil Mansuri

Ramin Farzaneh-Far

Doctorate Degree

Doctorate Degree

The Johns Hopkins University School of Medicine College/University

Josh Bilenker

Shao Lee Lin

Doctorate Degree

Doctorate Degree

Pharmaceuticals: Major

Linda Higgins

Russell Cox

Chief Tech/Sci/R&D Officer

Sales & Marketing

JUNO THERAPEUTICS INC Biotechnology

Robert Nelsen

Otello Stampacchia

Founder

Director/Board Member

Investment Managers

Christopher Griffith

Jung Choi

Corporate Officer/Principal

Corporate Officer/Principal

JANUX THERAPEUTICS, INC. Biotechnology

Charles Winter

Wayne Godfrey

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Statistik

International

Vereinigte Staaten 48
Frankreich 2
Niederlande 2
Vereinigtes Königreich 2

Sektoral

Health Technology 31
Consumer Services 15
Commercial Services 4
Finance 3

Operativ

Director/Board Member 445
Corporate Officer/Principal 248
Independent Dir/Board Member 132
Undergraduate Degree 84
Chief Tech/Sci/R&D Officer 75
  1. Börse
  2. Insiders
  3. Nicole White
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT